National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease.
about
Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologistsAddressing the challenges of phenotyping pediatric pulmonary vascular diseaseImplications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.
P2860
National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
National Heart, Lung, and Bloo ...... or pulmonary vascular disease.
@en
National Heart, Lung, and Bloo ...... or pulmonary vascular disease.
@nl
type
label
National Heart, Lung, and Bloo ...... or pulmonary vascular disease.
@en
National Heart, Lung, and Bloo ...... or pulmonary vascular disease.
@nl
prefLabel
National Heart, Lung, and Bloo ...... or pulmonary vascular disease.
@en
National Heart, Lung, and Bloo ...... or pulmonary vascular disease.
@nl
P2093
P1433
P1476
National Heart, Lung, and Bloo ...... or pulmonary vascular disease.
@en
P2093
Carol J Blaisdell
Ivan M Robbins
Steven H Abman
Timothy M Moore
P304
P356
10.1161/CIRCULATIONAHA.112.092924
P407
P577
2012-03-02T00:00:00Z